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NeurodegenerationTumour necrosis factor-a (TNF-a) is a pro-inﬂammatory cytokine, expressed in many brain pathol-
ogies and associated with neuronal loss. We show here that addition of TNF-a to neuronal–glial
co-cultures increases microglial proliferation and phagocytosis, and results in neuronal loss that
is prevented by eliminating microglia. Blocking microglial phagocytosis by inhibiting phagocytic
vitronectin and P2Y6 receptors, or genetically removing opsonin MFG-E8, prevented TNF-a induced
loss of live neurons. Thus TNF-a appears to induce neuronal loss via microglial activation and
phagocytosis of neurons, causing neuronal death by phagoptosis.
 2014 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical
Societies. This is an open access article under the CC BY license (http://creativecommons.org/licenses/
by/3.0/).1. Introduction that TNF-a contributes to a variety of brain pathologies, such asTumour necrosis factor-a (TNF-a) is a pro-inﬂammatory cyto-
kine, central to the regulation of inﬂammation in body and brain.
In the healthy brain, it is expressed at very low levels by a variety
of brain cells including neurons [29], but microglia (brain macro-
phages) and astrocytes, activated by pathogens or damage via pat-
tern recognition receptors such as Toll-like receptors (TLRs),
express and release high levels of TNF-a [18,13,33,21]. Thus the
damaged or diseased brain contains high levels of TNF-a, includ-
ing during brain trauma, ischemia, and neurodegenerative condi-
tions [8,22]. TNF-a activates microglia and astrocytes via TNF
receptors 1 (TNFR1) and 2 (TNFR2) [11], which activate the
phagocyte NADPH oxidase (PHOX) [20], caspase-8 [2] and NF-jB
[5], resulting in the expression of further pro-inﬂammatory and
phagocytic genes that increase the ability of glia to deal with
pathogens and damage [31]. However, high and sustained levels
of TNF-a can lead to neuronal damage [10], and there is evidenceischemic stroke, Alzheimer’s disease, Parkinson’s disease, and
multiple sclerosis [8,22]. The mechanisms by which TNF-a is
damaging to neurons is unclear, but the inﬂammatory activation
of glia may contribute.
In culture, we have found that activation of microglial TLRs
results in high levels of TNF-a production [13,23,15] and TNF-a
in turn stimulates microglial proliferation [20]. We subsequently
found that activation of microglia via TLR2 or TLR4 caused delayed
neuronal loss via activating microglial phagocytosis of stressed-
but-viable neurons [23]. Cell death caused by the cell being phago-
cytosed is called ‘phagoptosis’ with the deﬁning characteristic that
inhibition of phagocytosis or phagocytic signalling prevents death
of the cell [6]. TLR activation of microglia causes: (i) release of oxi-
dants from microglia that induce neurons to reversibly expose the
‘eat-me’ signal phosphatidylserine, (ii) release of the opsonin milk
fat globule EGF factor-8 (MFG-E8) from microglia and astrocytes
that binds exposed phosphatidylserine on neurons and activates
their phagocytosis via the microglial vitronectin receptor (VNR),
and (iii) activation of the phagocytic capacity of microglia via
upregulation of Mer tyrosine kinase and other phagocytic proteins
[23,24,7].
As activation of microglia can cause both TNF-a production and
neuronal phagoptosis, we tested here whether soluble, extracellu-
lar TNF-a was able and sufﬁcient to induce microglia-dependent
neuronal loss by phagoptosis.
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2.1. Reagents
Rat recombinant TNF-a (Sigma), lipopolysaccharide from Sal-
monella typhimurium (Sigma), Alexa Fluor 488 conjugate of isolec-
tin B4 from Griffonia simplicifolia (Invitrogen), carboxylate-modiﬁed
ﬂuorescent microspheres (Invitrogen), cyclo(RGDfV) peptide
(Bachem), recombinant MFG-E8 (R&D Systems), human soluble
TNF receptor inhibitor/Fc chimera (GenScrip Corporation), and
MRS2578 compound (Tocris). Cell culture reagents were from
PAA. Other reagents were from Sigma.
2.2. Primary cell culture and treatment
All experiments were performed in accordance with the UK Ani-
mals (Scientiﬁc Procedures) Act (1986) and approved by the Cam-
bridge University local ethical committee. Primary mixed
neuronal/glial cultures from postnatal days 5–7 Wistar rat or
Mfge8/ mice [30] cerebella were prepared as described previ-
ously [16]. Cells were plated at a density of 5  105 cells/well on
poly-L-lysine coated 24-well plates. Glial cultures and pure microg-
lial cultures were prepared as described previously [3]. Microglia
cells were depleted from the cultures with L-leucine methyl ester
as described previously [23]. Cells were stimulated at 7–9 days
in vitro with TNF-a (50 ng/ml) or LPS (100 ng/ml), and
cyclo(RGDfV) peptide (50 lM), recombinant MFG-E8 (0.4 lg/ml)
or soluble TNF receptor inhibitor (100 ng/ml) were added together
with TNF-a, whereas MRS2578 compound (1 lM) was added every
day. Cell densities after treatment were evaluated as described pre-
viously [27]. Neurons with regular soma shape and normal nuclear
Hoechst 33342 staining were counted as alive, neurons with con-
densed chromatin were considered as apoptotic, whereas neurons
staining with propidium iodide were deﬁned as necrotic.
2.3. Microglial phagocytosis of beads
Phagocytic capacity of microglial cells was evaluated as
described previously [27]. In short, pure microglial culture was
treated with 50 ng/ml TNF-a for 24 h before 3 ll of 1:10 dilution
of 1 lm ﬂuorescently labelled carboxylate-modiﬁed microspheres
were added, and cells were incubated for 2 h at 37 C, 5% CO2.
The medium was removed, and the culture was washed several
times to remove excess beads. Microglia cells were then labelledFig. 1. TNF-a stimulates microglial proliferation and phagocytosis. (A) Treatment with TN
added 24 h after the ﬁrst) signiﬁcantly increase microglial density in mixed neuronal/glia
ml for 24 h) increases the phagocytic uptake of ﬂuorescent 1 lm carboxylate-modiﬁed mi
effect with lipopolysaccharide (LPS, 100 ng/ml). (C) Pre-treatment of microglia with TN
neurons when the microglia were added to a healthy neuronal–glial culture for 6 h. Th
debris are quantiﬁed. Data are presented as means ± S.E.M. of P3 cultures (A and B) orwith Alexa Fluor 488-tagged isolectin B4 (2 lg/ml) and bead num-
ber per cell was evaluated in >50 cells per condition.
2.4. Microglial phagocytosis of neurons
Glial cultures were treated ± 50 ng/ml of TNF-a for 24 h.
Microglia from untreated and treated ﬂasks were detached from
other glia by shacking the ﬂask. 105 microglia (untreated and trea-
ted) were added to each well (in a 24 well plate) of a mixed neu-
ronal/glial culture, which had previously been stained for 15 min
with TAMRA (red ﬂuorescence) and washed. Phagocytosis was
assayed in a medium half from a glial culture and half from a
mixed neuronal/glial culture. Phagocytosis of neurons by microglia
was evaluated by microscopy at 6 h after adding microglia as the
number of microglia per ﬁeld containing red ﬂuorescent debris.
Cells were also stained with Hoechst 33342 (for nuclei) and green
ﬂuorescent isolectin B4 (for microglia).
2.5. Statistical analysis
For all experiments, each condition/treatment was repeated at
least in duplicate, and each experiment was replicated in at least
three independent cultures – except the experiment on microglial
phagocytosis of neurons, which was repeated in quadruplicate but
on one culture. Statistical analysis was performed using IBM SPSS
Statistics v20 software. Normality of data was veriﬁed by Shap-
iro–Wilk test. Means were compared by one-way ANOVA, and
the signiﬁcance of the difference between each treatment mean
and the control or TNF-a treatment mean was quantiﬁed by
post-hoc Bonferroni tests. All such signiﬁcant changes are reported
in the Figures – those not reported as signiﬁcant are not signiﬁcant.
P values < 0.05 were considered as signiﬁcant. Numbers of alive,
apoptotic and necrotic neurons were compared separately. All data
presented are expressed as mean ± standard error of the mean
(S.E.M.).
3. Results and discussion
TNF-a (50 ng/ml, equivalent to 3 nM of monomer) caused
microglial proliferation (Figs. 1A and 2A), stimulated microglial
phagocytosis of beads (Fig. 1B), and increased the phagocytosis of
neurons by added microglia (Fig. 1C). However, in mixed neuro-
nal–glial cultures, a single dose of TNF-a was not sufﬁcient to
cause signiﬁcant neuronal loss (Fig. 2B). As extracellular TNF-a isF-a, added either as a single dose (50 ng/ml) or two doses (second dose of 50 ng/ml
l cultures, 3 or 7 days after the ﬁrst addition of TNF-a. (B) Addition of TNF-a (50 ng/
crospheres in pure microglial culture, but does not have a synergistic or antagonistic
F-a (50 ng/ml for 24 h) increased the proportion of microglia that phagocytosed
e numbers of microglia per ﬁeld that either contained or did not contain neuronal
of 4 replicates on the same culture (C). ⁄/⁄⁄P < 0.05/0.01 versus untreated control.
Fig. 2. TNF-a induces neuronal loss in mixed cultures. (A) Representative images of culture treated for 3 or 7 days with two doses of TNF-a (50 ng/ml, second dose added 24 h
after the ﬁrst one). Cell nuclei are labelled with Hoechst 33342, necrotic cells are labelled with propidium iodide, microglia cells are labelled with isolectin B4. Scale bars,
25 lm. (B) One dose of TNF-a (50 ng/ml) is not sufﬁcient to induce neuronal loss within 3 days of treatment. Two doses of TNF-a (second dose of 50 ng/ml added 24 h after
the ﬁrst one) induce signiﬁcant neuronal loss within ﬁrst 3 days of treatment. No more neurons are lost for up to 7 days. Data are presented as means for P3 independent
experiments; ± S.E.M. of live neurons; ⁄⁄⁄P < 0.001 versus control.
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ronal loss could be induced by a second bolus of 50 ng/ml TNF-a
added 24 h after the ﬁrst dose, and cultures were incubated for a
further 2 or 6 days (in total 3 or 7 days treatment, respectively).
Two doses of TNF-a were sufﬁcient to induce signiﬁcant neuronal
loss after 3 days of treatment (Fig. 2A and B). There was no further
loss of neurons for up to 7 days (Fig. 2B), even though prolonged
treatment with TNF-a increased microglial densities by up to ten
times (Fig. 1A). This is in accordance with previously published
data demonstrating that phagoptosis induced with different stim-
uli is maximal 2–3 days after culture stimulation [23,27]. Higher
concentration (100 ng/ml) of TNF-a did not further increase
microglial numbers or neuronal loss (data not shown). Adding sol-
uble TNF receptor inhibitor to chelate extracellular TNF-a pre-
vented the neuronal loss induced by TNF-a (Fig. 3B), indicating
that loss was indeed due to TNF-a rather than some contaminant
such as endotoxin.
Treatment with TNF-a did not increase the number of apoptotic
or necrotic neurons in the neuronal glial cultures (Fig. 2A and B),
suggesting that TNF-awas not directly toxic to the neurons. There-
fore we tested whether eliminating microglia from the cultures by
treating them with L-leucine methyl ester [23] would prevent TNF-
a-induced neuronal loss. There was no neuronal death or loss in
microglia-deﬁcient cultures stimulated with TNF-a (Fig. 3A), indi-
cating that TNF-awas not directly toxic to neurons, and the neuro-
nal loss required the presence of microglia.
Microglia-induced loss of neurons may be mediated via variety
of mechanisms: microglial release of glutamate to induceFig. 3. TNF-a induced neuronal loss requires microglia, and is prevented by a TNFR in
microglial cells with L-leucine-methyl ester (LME). (B) Soluble TNF receptor inhibitor (sTN
means for P3 independent experiments, ± S.E.M. of live neurons; ⁄⁄⁄P < 0.001 versus conexcitotoxicity [14], microglial neurotoxic mediators (such as reac-
tive oxygen species) [19] that could cause neuronal apoptosis or
detachment from the culture, or neuronal death executed by
microglial phagocytosis. We have previously shown that microglial
phagoptosis of stressed-but-viable neurons depends on neuronal
exposure of phosphatidylserine [23,27]. Exposed phosphatidylser-
ine is bound by the soluble opsonin milk fat globule EGF factor-8
(MFG-E8), which is in turn recognized by the microglial vitronectin
receptor (VNR, an avb3 or avb5 integrin) [28,12,26]. To investigate
whether microglia might contribute to TNF-a-induced neuronal
loss by phagocytosing viable neurons, we targeted the phagocytic
MFG-E8/VNR pathway. Inhibition of phagocytosis with speciﬁc
VNR inhibitor cyclo(RGDfV) peptide prevented the loss of neurons
induced by TNF-a (Fig. 4A), indicating that neuronal loss induced
by TNF-a was dependent on VNR.
In order to test whether the VNR-speciﬁc opsonin MFG-E8 was
required for TNF-a-induced neuronal loss, we isolated neuronal–
glial cultures from the cerebella ofMfge8/mice [30]. The amount
of necrotic neurons in these untreated cultures was higher
(Fig. 4B). Addition of TNF-a induced no neuronal loss in these cul-
tures lacking MFG-E8 (Fig. 4B). However, TNF-a-induced neuronal
loss in Mfge8/ culture was reconstituted by adding recombinant
MFG-E8 protein together with TNF-a, whereas adding MFG-E8
alone had no effect (Fig. 4B). Thus MFG-E8 is required for TNF-a-
induced neuronal loss.
The microglial P2Y6 receptor is required for microglial phagocy-
tosis of neurons, as UDP released from damaged neurons induces
formation of the phagocytic cup via activating microglial P2Y6hibitor. (A) Neuronal loss induced by TNFa is prevented by selective depletion of
F RI, 100 ng/ml) prevents neuronal loss induced by TNF-a. (B) Data are presented as
trol, ###P < 0.001 versus TNF-a.
Fig. 4. Inhibition of phagocytic signalling prevents neuronal loss and death induced by TNF-a. (A) Loss of neurons induced by TNF-a (two doses of 50 ng/ml for 3 days) is
prevented by blocking the phagocytosic receptor VNR with cyclo(RGDfV) peptide (cRGD, 50 lM). (B) TNF-a does not induce neuronal loss in neuronal/glial cultures from
Mfge8/mouse cerebella, but the loss is reconstituted by the addition of recombinant MFG-E8 protein (rMFG-E8, 0.4 lg/ml, added together with the ﬁrst dose of TNF-a). (C)
Neuronal loss in mixed neuronal/glial cultures treated with tumour necrosis factor-a (TNF-a, 50 ng/ml) for 3 days is prevented by the selective P2Y6 inhibitor MRS2578 (MRS,
1 lM, added every day). Data are presented as means forP3 independent experiments, ± S.E.M. of live neurons, ⁄⁄/⁄⁄⁄P < 0.01/0.001 versus control, ##/###P < 0.01/0.001 versus
TNF-a, ++P < 0.01 versus rMFG-E8.
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required for the microglial phagocytosis of neurons induced by
LPS or amyloid b [25]. So we tested whether inhibition of P2Y6 with
1 lMMRS2578 prevented TNF-a-induced neuronal loss, and found
that it did (Fig. 4C), indicating that activation of the P2Y6 phago-
cytic receptor is required for this neuronal loss.
Importantly, inhibition of P2Y6, inhibition of VNR or lack of
MFG-E8 prevented neuronal loss without statistically signiﬁcant
increases of the number of apoptotic or necrotic neurons in the cul-
tures treated with TNF-a (Fig. 4). If microglia had been phagocytos-
ing dead or dying neurons then inhibition of their phagocytosis
would have left necrotic or apoptotic neurons. Whereas we found
that inhibition of phagocytosis prevented neuronal loss and left
viable neurons, indicating that the neurons must have been viable
at the time of their phagocytosis, i.e. the neurons died by phagop-
tosis. These data demonstrated that TNF-a induces neuronal loss
that is mediated by microglial phagocytosis of otherwise viable
neurons recognized via the MFG-E8/VNR pathway.
It has been previously established that TNF-a activates microg-
lia and triggers NADPH oxidase activation [9,13]. Even though TNF-
a itself is not directly neurotoxic [1], it may contribute to neuronal
damage due to microglial activation. Here we demonstrated that
TNF-a induced strong microglial proliferation (Fig. 1A), which is
often used as an indicator of microglial activation. In addition,
TNF-a increased the microglial phagocytic capacity (Fig. 1B), thus
promoting microglial uptake of neurons. Under inﬂammatory con-
ditions TNF-a may be released by either activated microglial cells
or astrocytes. While it has been previously shown that microglia
cells produce TNF-a when activated with such triggers as LPS
[23] or amyloid b [13], whether TNF-a levels released by microglia
are sufﬁcient to induce phagoptosis has not yet been demon-
strated. TNF-a concentrations that were used in this study to
induce phagoptosis were signiﬁcantly higher than those found in
cerebrospinal ﬂuid of patients with neurodegenerative diseases
(0.8 ng/ml in Alzheimer’s disease; [32]) or animal models of brain
inﬂammation (0.4 ng ml in rat experimental meningitis [4]). How-
ever, it is difﬁcult to extrapolate from these studies to what might
be focal/local extracellular concentration of TNF-a in diseased
brain. The relevance of TNF-a for phagoptosis in vivo is yet to be
determined.
Treatment with TNF-a alone was sufﬁcient to induce microglia-
dependent neuronal loss (Fig. 2A and B). Furthermore, this loss of
neurons was prevented by the VNR inhibitor cyclo(RGDfV) peptide
and in Mfge8/ cultures, indicating that neuronal loss wasmediated by the MFG-E8/VNR phagocytic pathway of microglial
cells (Fig. 4A and B). Inhibition of P2Y6 also prevented neuronal loss
indicating that this neuronal loss also required the UDP/P2Y6 phag-
ocytic pathway (Fig. 4C). While pharmacological treatments used
in this study may potentially have had side effects unrelated to
phagocytosis (such as changes in microglial secretome), it is unli-
kely that such effects could have blocked neuronal death or pro-
moted neuronal survival.
Altogether, the data presented here revealed that TNF-a induces
neuronal death by microglial phagocytosis. Consequently the
delayed neuronal loss that occurs in many pathologies accompa-
nied by inﬂammation may be due to TNF-a-induced phagoptosis,
and might be prevented by blocking TNF-a production or function,
its receptor, microglial activation, MFG-E8, the vitronectin receptor
or the P2Y6 receptor.
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